Literature DB >> 3516390

Influence of glucose concentration on growth and formation of necrosis in spheroids derived from a human bladder cancer cell line.

I F Tannock, I Kopelyan.   

Abstract

Spheroids derived from the human bladder cancer cell line MGH-U1 were initiated in spinner culture and then transferred to multiwell plates which contained medium with varying concentrations of glucose and pyruvate. Growth of individual spheroids was monitored, and at different times after transfer spheroids were sectioned and the diameter of the necrotic center and the thickness of the viable rim were determined. In normal medium containing glucose (1 g/liter; 5.5 mM), spheroid diameter increased linearly with time, growing from approximately 400 micron to approximately 1200 micron in 8 days, and most spheroids did not develop central necrosis. Increase in glucose concentration up to 5 g/liter had no effect on spheroid growth. Lower glucose concentration decreased the rate of spheroid growth, but large effects were observed only at glucose concentration lower than 100 mg/liter. Spheroids developed central necrosis at 2-4 days after transfer to glucose-deficient medium, and the diameter of the necrotic center increased more rapidly than the diameter of the spheroid. There was an approximately linear relationship between thickness of the viable rim in 5-6-day spheroids and glucose concentration in the range of zero (rim thickness, approximately 150 micron) to 500 mg/liter (rim thickness, approximately 400 micron). The presence or absence of pyruvate (110 mg/liter) in the medium had no effect on spheroid growth or formation of necrosis. These results suggest that limited penetration of glucose may be one of the factors that contribute to cell death in solid tumors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516390

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  14 in total

1.  Insulin, glucose and the increased risk of cancer in patients with type 2 diabetes.

Authors:  J A Johnson; M Pollak
Journal:  Diabetologia       Date:  2010-07-20       Impact factor: 10.122

2.  Distributions of oxygen, nutrient, and metabolic waste concentrations in multicellular spheroids and their dependence on spheroid parameters.

Authors:  K Groebe; W Mueller-Klieser
Journal:  Eur Biophys J       Date:  1991       Impact factor: 1.733

3.  HuR is a post-transcriptional regulator of core metabolic enzymes in pancreatic cancer.

Authors:  Richard A Burkhart; Danielle M Pineda; Saswati N Chand; Carmella Romeo; Eric R Londin; Edward D Karoly; Joseph A Cozzitorto; Isidore Rigoutsos; Charles J Yeo; Jonathan R Brody; Jordan M Winter
Journal:  RNA Biol       Date:  2013-06-13       Impact factor: 4.652

Review 4.  Diabetes and cancer (1): evaluating the temporal relationship between type 2 diabetes and cancer incidence.

Authors:  J A Johnson; B Carstensen; D Witte; S L Bowker; L Lipscombe; A G Renehan
Journal:  Diabetologia       Date:  2012-04-04       Impact factor: 10.122

Review 5.  What is the malignant nature of human ductal carcinoma in situ?

Authors:  Virginia Espina; Lance A Liotta
Journal:  Nat Rev Cancer       Date:  2010-12-02       Impact factor: 60.716

6.  Attacking breast cancer at the preinvasion stage by targeting autophagy.

Authors:  Virginia Espina; John Wysolmerski; Kirsten Edmiston; Lance A Liotta
Journal:  Womens Health (Lond)       Date:  2013-03

7.  The influence of metformin in the etiology of selected cancers.

Authors:  Monika Pawałowska; Anna Markowska
Journal:  Contemp Oncol (Pozn)       Date:  2012-07-06

8.  Changes in tumour morphology with alterations in oxygen availability: further evidence for oxygen as a limiting substrate.

Authors:  D G Hirst; V K Hirst; B Joiner; V Prise; K M Shaffi
Journal:  Br J Cancer       Date:  1991-07       Impact factor: 7.640

9.  Influence of reduced concentration of L-glutamine on growth and viability of cells in monolayer, in spheroids, and in experimental tumours.

Authors:  I F Tannock; D Steele; J Roberts
Journal:  Br J Cancer       Date:  1986-11       Impact factor: 7.640

10.  Variable presence of hypoxia in M006 human glioma spheroids and in spheroids and xenografts of clonally derived sublines.

Authors:  A J Franko; M B Parliament; M J Allalunis-Turner; B G Wolokoff
Journal:  Br J Cancer       Date:  1998-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.